# Evaluation of the Relative Bioavailability of Bosutinib Capsules Under Fed Condition and Estimation of Food Effect on Orally Administered Bosutinib Capsule

> **NCT05032690** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 32 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Bosutinib capsule
- **DRUG:** Bosutinib capsule
- **DRUG:** Bosutinib
- **DRUG:** Bosutinib capsule

## Key facts

- **NCT ID:** NCT05032690
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-19
- **Primary completion:** 2022-06-25
- **Final completion:** 2022-06-25
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05032690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05032690, "Evaluation of the Relative Bioavailability of Bosutinib Capsules Under Fed Condition and Estimation of Food Effect on Orally Administered Bosutinib Capsule". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05032690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*